Roche attempt to retool arthritis drug for COVID-19 pneumonia fails trial – Reuters India
A late-stage clinical trial of Roche’s Actemra/RoActemra drug to treat patients hospitalised with severe COVID-19-related pneumonia failed, the Swiss drugmaker said on Wednesday.
